.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
Julphar
Cantor Fitzgerald
QuintilesIMS
US Army
Queensland Health
Dow
Citi
McKinsey

Generated: November 20, 2017

DrugPatentWatch Database Preview

KETOPROFEN Drug Profile

« Back to Dashboard

What is the patent landscape for Ketoprofen, and when can generic versions of Ketoprofen launch?

Ketoprofen is a drug marketed by Heritage Pharms Inc, Teva, Aurolife Pharma Llc, Mylan, Perrigo, Actavis Labs Fl Inc, and Alkermes Gainesville. and is included in ten NDAs.

The generic ingredient in KETOPROFEN is ketoprofen. There are twenty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms Inc
KETOPROFEN
ketoprofen
CAPSULE;ORAL074014-001Jan 29, 1993RXNoNo► Subscribe► Subscribe► Subscribe
Mylan
KETOPROFEN
ketoprofen
CAPSULE, EXTENDED RELEASE;ORAL075679-001Feb 20, 2002ABRXNoYes► Subscribe► Subscribe► Subscribe
Aurolife Pharma Llc
KETOPROFEN
ketoprofen
CAPSULE;ORAL074024-001Dec 29, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
KETOPROFEN
ketoprofen
CAPSULE;ORAL073515-001Dec 22, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
KETOPROFEN
ketoprofen
CAPSULE, EXTENDED RELEASE;ORAL075270-002Mar 24, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurolife Pharma Llc
KETOPROFEN
ketoprofen
CAPSULE;ORAL074024-002Dec 29, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
KETOPROFEN
ketoprofen
CAPSULE, EXTENDED RELEASE;ORAL075679-003Feb 20, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
KETOPROFEN
ketoprofen
CAPSULE, EXTENDED RELEASE;ORAL075270-001Mar 24, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms Inc
KETOPROFEN
ketoprofen
CAPSULE;ORAL074014-002Jan 29, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms Inc
KETOPROFEN
ketoprofen
CAPSULE;ORAL074014-003Jan 29, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Baxter
Covington
US Department of Justice
Chinese Patent Office
Mallinckrodt
Harvard Business School
Healthtrust
Johnson and Johnson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot